[Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
D000368:Aged; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006023:Glycoproteins; D006131:Growth Inhibitors; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology; D008222:Lymphokines; D008297:Male; D008875:Middle Aged
D006023:Glycoproteins; D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D003561:Cytarabine
Wstepne wyniki leczenia ostrej białaczki nielimfoblastycznej i dysplazji szpiku małymi dawkami arabinozydu cytozyny.